Eli Lilly and Company
DISUBSTITUTED PYRAZOLE COMPOUNDS
Last updated:
Abstract:
The present invention provides a compound of Formula I ##STR00001## or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.
Status:
Application
Type:
Utility
Filling date:
16 Jun 2020
Issue date:
17 Dec 2020